Programmed cell death-1 inhibition in lymphoma
Eliza A Hawkes, Andrew Grigg, Geoff Chong
The Lancet Oncology | ELSEVIER SCIENCE INC | Published : 2015
EAH receives funding from the North Eastern Metropolitan Integrated Cancer Services. AG declares no competing interests. GC receives funding from Amgen, Novartis, and Astellas.